As the Coronavirus disease continues to spread throughout the world, some countries and organizations are making good use of diagnostic tests for SARS-Co-V-2 antibodies to slow the spread of the coronavirus. Due to the challenges that health care professionals face and the need to expand access to COVID-19 testing, an affordable but accurate alternative solution was required.
Rapid COVID-19 antibody test kits used together with periodic monitoring can inform policymakers whether to relax certain restrictions so that people may return to their everyday lives. Most nations, organizations, and independent laboratories rely on serology test results to understand how SARS-Co-V-2 antibodies work.
Reliable coronavirus antibody test kits have the advantage of rapidity, simplicity, convenience, high accuracy, and affordability. They make up for the shortcomings of time consumption, the use of additional resources, the need for highly skilled medical professionals, and low positive detection rates of Polymerase chain reaction (PCR) tests.
Since the U.S. Food and Drug Administration (FDA) issued the first Emergency Use Authorization (EUA) on antibody test devices, developers and manufacturers have been ramping up their production process to meet the demand for antibody test kits. These companies have the difficult task of making diagnostic tools more accurate and reliable.
The recent authorization of the first point-of-care (POC) rapid COVID-19 antibody test kit by the FDA shows that developers are aiming to offers easy to use and fast solutions. For a very long time, there was a need for tests that can be used in POC settings such as a doctor’s office, medical offices, hospitals, workplaces, urgent care centers, schools, and emergency rooms.
One area of improvement where most rapid COVID-19 antibody test kit developers are keen on is the time it takes to complete the entire testing process, from blood collection to results. The new COVID-19 (SARS-Co-V-2) IgM/IgG antibody test kits are developed for point-of-care diagnostics (POC-Dx) and are strictly for use by health professionals.
Health care practitioners will no longer have to send blood samples to a central lab for testing. Previously antibody testing would require transporting the blood samples to a central lab, a process that consumes time and additional resources. The authorization of point-of-care serology tests has greatly addressed this issue.
Currenly, diagnostic tests for COVID-19 antibodies can take less than 15 minutes to display results. This satisfies the need for timely and convenient testing of patients, especially in emergencies. The growing demand for antibody testing around the globe has led to the introduction of serology test kits that can produce results in record-breaking time, two minutes.
In just two minutes, you can now detect the presence of total antibodies to SARS-CoV-2 in a blood sample. Independent and government laboratories can now run more tests in less time, especially during emergencies or when PCR tests have failed. With the relaxation of travel restrictions, antibody testing has played a crucial part in awarding an “immunity passport” or “risk-free certificate”.
The presence of FDA EUA “semi-quantitative” COVID-19 antibody test kits in the market enables health care professionals to estimate the number of antibodies against SARS-CoV-2 that a patient produces during an infection. These measurements are helping scientists learn more about the behavior of SARS-CoV-2 and the existence of the antibodies detected.
Generally, new developments in the COVID-19 antibody test kits aim to improve performance, eliminate complex procedures, and reduce the waiting time. Developers are investing in innovative technologies in the design of uniquely, effective, and rapid serology tests.
The result obtained from any coronavirus antibody testing kit should be used to determine the extent of the spread of coronavirus in a population. Diagnostic tests for COVID-19 antibodies are not to be used to diagnose an active infection since they do not detect the virus itself. The result may indicate whether a patient has an active or recent infection with SARS-CoV-2.
From the onset of the pandemic, it is still hard to tell whether the presence of SARS-CoV-2 antibodies is proof of total immunity. As scientists continue to study the virus and do more research, patients are discouraged from interpreting positive results as having potential immunity from the COVID-19 virus. Failure to maintain social distancing and wearing masks in the public allows the virus to spread.
Rapid Connect Medical supplies the most cost-effective solutions for COVID-19 antibody testing. We distribute Lateral Flow Immunoassays that can easily and quickly detect two types of antibodies, Immunoglobulin M (IgM) and immunoglobulin G (IgG). In case you are wondering, these test kits meet the required standards for accurately detecting SARS-CoV-2 antibodies.
The special thing about using the combined IgG and IgM immunoassays is that the results are automatically displayed on the cassette window within a span of 2 to 15 minutes. Our rapid-ship response team can handle large rapid COVID-19 antibody test kit orders of up to 10,000,000, or more, which are completely covered by most insurance companies including Medicare.
The performance metrics of the COVID-19 IgG/IgM rapid test devices are as follows:
· Accuracy: 90.40%
· Sensitivity: 100%
· Specificity: 98.80%
The POC Lateral Flow Immunoassays sold by Rapid Connect Medical resemble the home pregnancy test. These COVID-19 IgG/IgM rapid test kits are authorized for use with whole blood, serum, plasma, and whole blood. Whole blood samples are collected using a fingerstick. The blood sample from the patient’s fingertip is then run through the test device.
Inside the kit you will find the following:
· IgG and IgM antibody detection test cassette
· Blood pipette
· Buffer solution
· Silver sterile packet
Most organizations and nations lack lab facilities, supplies, or technicians to administer molecular tests. One can use serology tests for surveillance and tracking the spread of the COVID-19 virus in a target population; usually high prevalence areas.
For more information on Coronavirus (SARS-CoV-2) IgM/IgG rapid test kits and how to make your first large test orders, please feel free to contact the Rapid Connect Medical sales team.
The rapid COVID-19 antibody test kits you will find on the market are designed to detect SARS-CoV-2-specific antibodies. The ones distributed by Rapid Connect Medical are FDA research approved and evaluated and validated by comprehensive clinical studies. This antibody test kit was developed in response to the COVID-19 global pandemic and offers a power tool for health care providers. The immune response produced by a Coronavirus viral infection is what this test measures. The CDC testing standards for laboratories were strictly followed during the clinical trials for our antibody test kit.
This is a serology elisa based test for SARS-CoV-2 antibodies in serum or plasma components of blood. Information on the collection data, total sample size, and validation of lab samples can be found here for review. Interpretations of test results should be confirmed with a lab and a a medical professional should diagnose your infection status not only on the sole basis of your rapid test kit results. This rapidtest should be performed by a licensed medical professional and your infection status determination may require additional tests. With the presence for IgG antibodies people can have immunity for some time. While viruses such as influenza have been a problem in the past, Covid-19 is a serious problem we aim to help eliminate.
The kits used for diagnostic tests for COVID-19 antibodies are usually designed for research use or qualitative detection of coronavirus, and not home use. Also, they can only be used to test the presence of IgG and IgM antibodies against SARS-CoV-2. Since they are aiding tools to RT-PCR or CT scanning, a clinical diagnosis of COVID-19 should be done by a healthcare professional or physician.
An antibody detection test cassette contains antigens from SARS-CoV-2 combined with gold nanoparticles. The device has two wells (one for specimen and one buffer) and a control region on the upper end. Two types of antibodies are of great importance in diagnostic tests for COVID-19 antibodies: Immunoglobulin M (IgM) and Immunoglobulin G (IgG).
The importance of the gold nanoparticles in the detection test cassette is to create a colored line in the control region. Antigens targeting a specific antibody are located in their respective regions on the nitrocellulose membrane of the test cassette. The IgG and IgM regions are coated with anti-human antibodies for each.
The sampling done with the rapid COVID-19 antibody test kit cassette using lateral flow from Rapid Connect Medical will give you the IgG and IgM detectable diagnostics results from between two and ten minutes. It can be used for reference in combination with the results from an RT-PCR (reverse transcriptase-polymerase chain reaction) test. A single finger prick to draw blood can be used with our kit that detects antibodies. This is a combo of IgG and IgM detection on one cassette. This positive or negative result can be detected as soon as 3 days after exposure to COVID-19 (sometimes before the onset of symptoms occur).
Knowing if you have active igM antibodies even in the first week of infection can help get the best treatment for an infected person. If you do test positive, potentially exposed, or have traveled to a region with high infection rates, you should seek care from your doctor for treatment and continue to test for IgG antibodies daily until you are cleared to leave quarantine. The sensitivity, specificity, and accuracy or our antibody test kit is very high. This testing method for the public gives real time results and helps to identify initial infection before the severe flu like symptoms begin.
This kit is intended to be administered by a health care professionals and providers at a clinic or other health care facilities. Many of the faulty test kits were removed from the FDA EUA website; all of our test kits are authorized by the FDA and their data appears and is included on that website. Individuals can trust the validity and quality of the antibody test kits sold by Rapid Connect Medical. Now with the FDA EUA point of care authorization, people have the flexibility to test without a clia lab.
Rapid Connect Medical LLC distributes large orders of Coronavirus (SARS-CoV-2) IgM/IgG rapid test kits on a global scale. Rapid Connect Medical is the leading provider of Covid-19 Antibody test kits in 25 test kit packs, as well as bulk orders for large countries, companies, and organizations. If your institute or corporation is in the need of antibody test kits, feel free to email our sales team. The company covers the USA, Canada, South America, and European territories. Therefore, if you are from these areas, Rapid Connect Medical will be able to assist you with availability, pricing, and ordering. Our test kit is considered to be the best product on the market for rapid Covid-19 antibody testing. Healthcare professionals can have the confidence to measure the negative or positive presence of antibodies in their patients. By following the simple instructions, tests can be administered to know the interval or spike of new infections.This can help guide the national or local response.
Our test kits are FDA EUA (Emergency Use Authorization) Authorized, have the CE Declaration for authorized European Union distribution, and have an authorization for use by the HHS for Pharmacies and Pharmacists. Federal guidance has been issues for Rapid Connect Medical’s COVID-19 Antibody test kit that is 98.20% accurate with results in 2 to 10 minutes. Don’t take a risk using inferior test kits, our Antibody Test kits are tested in a biotechnology laboratory! The development of the technology for this screening standard with confirmed scientific accuracy is unique to Rapid Connect Medical‘s Antibody Test Kit.
If you are interested in order a large quantity for commercial, biomedical, biological, science, or pharmaceutical applications and have questions, feel free to book a call with our sales team. In response to the global demand, our manufacturers have the capacity to support your required production needs. Covid-19 testing is also covered by many insurance plans. For our update on insurance coverage from our website, that can be accessed here. Our newest test kit also has data from specimens collected by the Mayo clinic.
Certification and Authorization – COVID-19 antibody test kits from Rapid Connect Medical are safe for use under the Emergency Use Authorization (EUA) of the FDA (Food and Drug Administration). They also are authorized by The U.S. Department of Health and Human Services (HHS) for Pharmacy or Pharmacist use. The antibody test kits come with a CE Declaration, meaning that they are clear for use in countries that fall under the European Union.
Storage and Quality – the Coronavirus antibody testing kits from Rapid Connect Medical have a shelf life of 24 months from the date of manufacture.
Ease of Use – the COVID-19 antibody test kits from Rapid Connect Medical are easy to use and you can get your results in two to ten minutes. The antibody test kits are designed for medical professional use and not as an over-the-counter product for home use.
Technology – the rapid serologic COVID-19 antibody test kits from Rapid Connect Medical use lateral flow technology.
We offer fast shipping methods for our antibody test kits at an affordable rate. You can order test kits online at https://rapidconnectmedical.com/
Be sure to follow us on Facebook, LinkedIn, YouTube, and Twitter for updates, news, and new product announcements. We will also be having press events in the near future so keep an eye out for more news about Rapid Connect Medical!
Stop the Spread – Test Yourself Now